Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.565
-0.045 (-2.80%)
Mar 31, 2025, 1:21 PM EDT - Market open
BDTX Stock Forecast
BDTX's stock price has decreased by -69.13% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for BDTX stock have an average target of 15.6, with a low estimate of 12 and a high estimate of 20. The average target predicts an increase of 896.81% from the current stock price of 1.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BDTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +666.77% | Mar 18, 2025 |
Stifel | Stifel | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +858.47% | Mar 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +602.88% | Nov 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +602.88% | Oct 9, 2024 |
Wedbush | Wedbush | Buy Reiterates $16 | Buy | Reiterates | $16 | +922.36% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
from 232.50M
Revenue Next Year
n/a
EPS This Year
-1.25
from -1.27
EPS Next Year
-1.54
from -1.25
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | 20.4M | 73.4M | ||
Avg | n/a | 3.3M | 24.5M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | 2,117.6% | ||
Avg | - | - | 641.0% | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.86 | -0.81 | -0.72 | ||
Avg | -1.25 | -1.54 | -1.59 | ||
Low | -1.89 | -2.42 | -3.05 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.